References
- GBD. 2015 mortality and causes of death collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med. 2017;5:691–706.
- Ford E, Croft J, Mannino D, et al. COPD surveillance – United States, 1999-2011. Chest. 2013;144:284–305.
- Garg S, Kim L, Walker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 – COVID-NET, 14 states, March 1 –30, 2020. MMWR. 2020;69:1–7.
- Sikjær MG, Løkke A, Hilberg O. The influence of psychiatric disorders on the course of lung cancer, chronic obstructive pulmonary disease and tuberculosis. Respir Med. 2018;135:35–41.
- Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Rev Clin Gerontol. 2000;10(2):193–202.
- Holmes EA, O’Connor R, Perry VH, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action and for mental health science. Lancet Psychiatry. 2020:7:547–560. Published online 15th April.
- Yohannes AM, Mulerova H, Hanania NA, et al. Longterm course of depression trajectories in patients with COPD: A three year follow-up analysis of the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) cohort. Chest. 2016;149(4):916–926.
- Gunnell D, Appleby L, Arensman E, et al. Suicide risk and prevention during the COVID-19 pandemic. Lancet Psychiatry. 2020 April;21(7):468–471. Published online.
- Bjelland I, Dahl AA, Haug TT, et al. The validity of the hospital anxiety and depression scale. J Psychiatr Res. 2002;52:69–77.
- Lovibond SH, Lovibond PF. Manual for the depression anxiety stress scales. 2nd ed. Sydney, Australia: Psychology Foundation; 1995.
- Yohannes AM, Alexopoulos GS. Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes. Drugs Aging. 2014;31(7):483–492.
- Willgoss T, Yohannes AM, Goldbart J, et al. COPD and anxiety: its impact on patients’ lives. Nurs Times. 2011;107:16–19.